Anivive Lifesciences, a leading pet health company, was recently awarded the top Companion Animal Start-up for the Innovation Showcase at the Animal Health, Nutrition & Technology Innovation Europe summit held in London from March 6-8.
Animal Health, Nutrition & Technology Innovation Europe is the sector’s premier innovation conference. The Innovation Showcase is a unique opportunity where 20 of the most innovative companies are selected amongst 150 peer companies to present in front of the industry’s most influential figures and investors including Partners Group, Bank of America, GHO Capital, Digitalis Ventures, Google Ventures, Rabdan Holding, Stifle and CEOs from the top global animal health companies.
Anivive’s achievement was particularly notable due to its significant advancements in the development of the Valley Fever Vaccine for dogs and its breakthrough Feline Infectious Peritonitis (FIP) treatment.
Dylan Balsz, Anivive founder & CEO commented: “This is Europe’s most influential animal health summit, so to receive this award was an honor and we are very proud that the work we are doing within the pet healthcare sector has been recognized by our industry peers.”
The award highlights the company’s commitment to improving the health and well-being of companion animals worldwide.